4.7 Article

Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsons disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity

Related references

Note: Only part of the references are listed.
Article Neurosciences

Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease

Nada Saewanee et al.

Summary: The study demonstrated that metformin has significant neuroprotective effects on dopaminergic neurons and alpha-synuclein in a Parkinson's disease model, reducing neurodegeneration, inhibiting protein aggregation, and impacting gene expression, while not affecting the lifespan of the model organism. These findings suggest the potential therapeutic effects of metformin on Parkinson's disease, with further investigation needed to determine the precise mechanisms involved.

NEUROSCIENCE RESEARCH (2021)

Article Cell Biology

Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus

Maheedhar Kodali et al.

Summary: The study found that initiating metformin treatment in late middle age can improve cognitive function in old age, possibly through modulation of microglia, proinflammatory cytokines, and autophagy.

AGING CELL (2021)

Article Neurosciences

Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease

Debora Dalla Vecchia et al.

Summary: Ketamine has shown promising results in improving depressive-like behaviors and short-term memory impairment in an animal model of PD, indicating its potential for treating PD patients.

BRAIN RESEARCH BULLETIN (2021)

Article Neurosciences

Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice

Wilma Helena Oliveira et al.

Summary: The study showed that metformin improved spatial memory in diabetic mice by reducing p-Tau and beta-amyloid plaque load and inhibiting neuronal death.

EXPERIMENTAL BRAIN RESEARCH (2021)

Article Neurosciences

Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging

Young-Kyoung Ryu et al.

NEUROPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Unanchored tri-NEDD8 inhibits PARP-1 to protect from oxidative stress-induced cell death

Matthew J. Keuss et al.

EMBO JOURNAL (2019)

Review Psychiatry

Is There a Role of Autophagy in Depression and Antidepressant Action?

Nils C. Gassen et al.

FRONTIERS IN PSYCHIATRY (2019)

Article Genetics & Heredity

Adult neurogenesis and neurodegenerative diseases: A systems biology perspective

Emrin Horgusluoglu et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)

Article Neurosciences

AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration

Christina Alves Peixoto et al.

EXPERIMENTAL NEUROLOGY (2017)

Article Biochemistry & Molecular Biology

Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition

Sara Ahmed et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2017)

Review Clinical Neurology

Research in Parkinson's disease in India: A review

Pratibha Surathi et al.

ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2016)

Review Neurosciences

Reward and Aversion

Hailan Hu

ANNUAL REVIEW OF NEUROSCIENCE, VOL 39 (2016)

Article Neurosciences

Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats

Thiago Pereira da Silva et al.

NEUROSCIENCE LETTERS (2016)

Article Biochemical Research Methods

Caspase-3 Activation Is a Critical Determinant of Genotoxic Stress-Induced Apoptosis

Gaurav S. Choudhary et al.

APOPTOSIS AND CANCER: METHODS AND PROTOCOLS, 2ND EDITION (2015)

Article Medicine, Research & Experimental

Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease

Mia Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)

Review Clinical Neurology

Inflamed moods: A review of the interactions between inflammation and mood disorders

Joshua D. Rosenblat et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)

Review Clinical Neurology

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Robert K. McNamara et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)

Review Neurosciences

Studies of Depression-Related States in Animal Models of Parkinsonism

Nicoletta Schintu et al.

JOURNAL OF PARKINSONS DISEASE (2012)

Article Behavioral Sciences

Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse

Lori M. Gorton et al.

BEHAVIOURAL BRAIN RESEARCH (2010)

Article Clinical Neurology

Anhedonia and activity deficits in rats: impact of post-stroke depression

S. H. Wang et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2009)

Article Clinical Neurology

The neuropathological basis for depression in Parkinson's disease

Pasquale G. Frisina et al.

PARKINSONISM & RELATED DISORDERS (2009)

Article Biochemistry & Molecular Biology

Dose translation from animal to human studies revisited

Shannon Reagan-Shaw et al.

FASEB JOURNAL (2008)

Article Neurosciences

Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress

Seiji Hitoshi et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2007)

Article Multidisciplinary Sciences

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

L Santarelli et al.

SCIENCE (2003)

Article Clinical Neurology

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

D Aarsland et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)